The primary use of dapagliflozin is for managing type 2 diabetes; however, it can also be employed for treating chronic kidney disease (CKD) and heart failure. Dapagliflozin is typically recommended as an alternative for individuals who have type 2 diabetes and are unable to tolerate metformin.